Bioinformatic profiling identifies the glutaminase to be a potential novel cuproptosis-related biomarker for glioma.

Ouyang, Zhen; Zhang, Hanyi; Lin, Wenrui; Su, Juan; Wang, Xianggui

Ouyang, Zhen; Zhang, Hanyi; Lin, Wenrui; Su, Juan; Wang, Xianggui.

Afiliação

Ouyang Z; Department of Dermatology, Hunan Key Laboratory of Skin Cancer and Psoriasis, Hunan Engineering Research Center of Skin Health and Disease, Xiangya Clinical Research Center for Cancer Immunotherapy, Xiangya Hospital, Central South University, Changsha, China.
Zhang H; National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Changsha, China.
Lin W; Department of Dermatology, Hunan Key Laboratory of Skin Cancer and Psoriasis, Hunan Engineering Research Center of Skin Health and Disease, Xiangya Clinical Research Center for Cancer Immunotherapy, Xiangya Hospital, Central South University, Changsha, China.
Su J; National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Changsha, China.
Wang X; Department of Dermatology, Hunan Key Laboratory of Skin Cancer and Psoriasis, Hunan Engineering Research Center of Skin Health and Disease, Xiangya Clinical Research Center for Cancer Immunotherapy, Xiangya Hospital, Central South University, Changsha, China.

Front Cell Dev Biol ; 10: 982439, 2022.

Article em En | MEDLINE | ID: mdl-36158220

Palavras-chave

cuproptosis; glutaminase; immunity; long non-coding RNAs; neuroinflammation; nonprogrammed cell death

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Cell Dev Biol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google